• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子动力学模拟和密度泛函理论研究鉴定寨卡病毒 NS3 解旋酶的潜在抑制剂。

Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.

机构信息

Department of Pharmaceutical Chemistry, School of Pharmaceutical & Populations Health Informatics, DIT University, Dehradun, 248009, India.

Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, 313001, India.

出版信息

Mol Divers. 2023 Aug;27(4):1689-1701. doi: 10.1007/s11030-022-10522-5. Epub 2022 Sep 5.

DOI:10.1007/s11030-022-10522-5
PMID:36063275
Abstract

Despite the various research efforts towards the drug discovery program for Zika virus treatment, no antiviral drugs or vaccines have yet been discovered. The spread of the mosquito vector and ZIKV infection exposure is expected to accelerate globally due to continuing global travel. The NS3-Hel is a non-structural protein part and involved in different functions such as polyprotein processing, genome replication, etc. It makes an NS3-Hel protein an attractive target for designing novel drugs for ZIKV treatment. This investigation identifies the novel, potent ZIKV inhibitors by virtual screening and elucidates the binding pattern using molecular docking and molecular dynamics simulation studies. The molecular dynamics simulation results indicate dynamic stability between protein and ligand complexes, and the structures keep significantly unchanged at the binding site during the simulation period. All inhibitors found within the acceptable range having drug-likeness properties. The synthetic feasibility score suggests that all screened inhibitors can be easily synthesizable. Therefore, possible inhibitors obtained from this study can be considered a potential inhibitor for NS3 Hel, and further, it could be provided as a lead for drug development.

摘要

尽管在针对寨卡病毒治疗的药物发现计划方面进行了各种研究努力,但尚未发现抗病毒药物或疫苗。由于持续的全球旅行,蚊子传播媒介和寨卡病毒感染暴露预计将在全球范围内加速。NS3-Hel 是一种非结构蛋白部分,参与多种功能,如多蛋白加工、基因组复制等。这使得 NS3-Hel 蛋白成为设计用于寨卡病毒治疗的新型药物的有吸引力的靶标。这项研究通过虚拟筛选鉴定了新型、有效的寨卡病毒抑制剂,并通过分子对接和分子动力学模拟研究阐明了结合模式。分子动力学模拟结果表明,蛋白质和配体复合物之间具有动态稳定性,并且在模拟期间结构在结合部位保持显著不变。在可接受范围内发现的所有抑制剂均具有类药性。合成可行性评分表明,所有筛选出的抑制剂都易于合成。因此,从这项研究中获得的可能抑制剂可以被认为是 NS3 Hel 的潜在抑制剂,并且可以进一步作为药物开发的先导物提供。

相似文献

1
Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies.基于分子动力学模拟和密度泛函理论研究鉴定寨卡病毒 NS3 解旋酶的潜在抑制剂。
Mol Divers. 2023 Aug;27(4):1689-1701. doi: 10.1007/s11030-022-10522-5. Epub 2022 Sep 5.
2
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.现有药物通过靶向NS2B-NS3相互作用作为寨卡病毒的广谱强效抑制剂。
Cell Res. 2017 Aug;27(8):1046-1064. doi: 10.1038/cr.2017.88. Epub 2017 Jul 7.
3
testing of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses.检测类黄酮作为登革热和 Zika 病毒蛋白酶和解旋酶结构域的潜在抑制剂。
PeerJ. 2022 Aug 4;10:e13650. doi: 10.7717/peerj.13650. eCollection 2022.
4
Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.寨卡病毒双组分NS2B-NS3蛋白酶的特性及变构小分子拮抗剂的结构辅助鉴定
Antiviral Res. 2017 Jul;143:218-229. doi: 10.1016/j.antiviral.2017.04.015. Epub 2017 Apr 29.
5
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.基于结构的已上市药物发现作为 Zika 病毒 NS2B-NS3 蛋白酶抑制剂,在体外和体内强效抑制 Zika 病毒感染。
Antiviral Res. 2017 Sep;145:33-43. doi: 10.1016/j.antiviral.2017.07.007. Epub 2017 Jul 14.
6
Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.发现和计算分析新型小分子寨卡病毒抑制剂。
Molecules. 2019 Apr 13;24(8):1465. doi: 10.3390/molecules24081465.
7
The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.通过整合虚拟筛选方法发现具有抗病毒活性的寨卡病毒 NS2B-NS3 抑制剂。
Eur J Pharm Sci. 2022 Aug 1;175:106220. doi: 10.1016/j.ejps.2022.106220. Epub 2022 May 23.
8
Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.针对寨卡病毒 NS3 解旋酶的 NTPase 位点进行抑制剂发现。
J Biomol Struct Dyn. 2020 Oct;38(16):4827-4837. doi: 10.1080/07391102.2019.1689851. Epub 2019 Nov 14.
9
Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.基于 C2 对称二醇的人免疫缺陷病毒蛋白酶抑制剂鉴定,针对寨卡病毒 NS2B-NS3 蛋白酶。
J Biomol Struct Dyn. 2020 Nov;38(18):5526-5536. doi: 10.1080/07391102.2019.1704882. Epub 2019 Dec 27.
10
Molecular mechanism of ATP and RNA binding to Zika virus NS3 helicase and identification of repurposed drugs using molecular dynamics simulations.Zika 病毒 NS3 解旋酶与 ATP 和 RNA 结合的分子机制及利用分子动力学模拟鉴定再利用药物。
J Biomol Struct Dyn. 2022;40(23):12642-12659. doi: 10.1080/07391102.2021.1973909. Epub 2021 Sep 13.

引用本文的文献

1
An integrated mutation-based immunoinformatic approach incorporating variability in epitopes: a study based on HIV subtype C.一种整合基于突变的免疫信息学方法并纳入表位变异性:一项基于HIV-1 C亚型的研究
Front Immunol. 2025 May 20;16:1540253. doi: 10.3389/fimmu.2025.1540253. eCollection 2025.
2
Unveiling the molecular activity of HIV towards the CD4: A study based on subtype C via docking and dynamics approach.揭示HIV对CD4的分子活性:一项基于C亚型通过对接和动力学方法的研究。
J Genet Eng Biotechnol. 2025 Mar;23(1):100457. doi: 10.1016/j.jgeb.2025.100457. Epub 2025 Jan 16.
3
Mechanistic study of α-mangostin derivatives as potent α-glucosidase inhibitors.

本文引用的文献

1
Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies.基于结构的虚拟筛选、分子动力学和密度泛函理论研究新型冠状病毒 2019 的潜在抑制剂。
J Biomol Struct Dyn. 2021 Aug;39(12):4449-4461. doi: 10.1080/07391102.2020.1791957. Epub 2020 Jul 15.
2
Mechanistic Insights into Zika Virus NS3 Helicase Inhibition by Epigallocatechin-3-Gallate.表没食子儿茶素-3-没食子酸酯对寨卡病毒NS3解旋酶抑制作用的机制研究
ACS Omega. 2020 May 4;5(19):11217-11226. doi: 10.1021/acsomega.0c01353. eCollection 2020 May 19.
3
α-山竹素衍生物作为强效α-葡萄糖苷酶抑制剂的机制研究
Mol Divers. 2025 Feb 25. doi: 10.1007/s11030-025-11141-6.
4
Employing Machine Learning-Based QSAR for Targeting Zika Virus NS3 Protease: Molecular Insights and Inhibitor Discovery.利用基于机器学习的定量构效关系研究寨卡病毒NS3蛋白酶:分子见解与抑制剂发现
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1067. doi: 10.3390/ph17081067.
Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
从 Commiphora mukul 树胶树脂中分离出的麦鲁酮 B 的一些新型 1,2,3-三唑杂合体的合成与生物评价:鉴定对前列腺癌细胞(PC-3)具有有效抗增殖作用的潜在先导化合物。
Eur J Med Chem. 2020 Feb 15;188:111974. doi: 10.1016/j.ejmech.2019.111974. Epub 2019 Dec 18.
4
Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.针对寨卡病毒 NS3 解旋酶的 NTPase 位点进行抑制剂发现。
J Biomol Struct Dyn. 2020 Oct;38(16):4827-4837. doi: 10.1080/07391102.2019.1689851. Epub 2019 Nov 14.
5
Combining molecular docking and molecular dynamics studies for modelling Staphylococcus aureus MurD inhibitory activity.结合分子对接和分子动力学研究建立金黄色葡萄球菌 MurD 抑制活性模型。
SAR QSAR Environ Res. 2019 Jan;30(1):1-20. doi: 10.1080/1062936X.2018.1539034. Epub 2018 Nov 8.
6
Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug design.计算研究取代吡嗪酮与促肾上腺皮质释放因子-1 受体的结合机制,旨在设计抗抑郁药物。
J Biomol Struct Dyn. 2019 Aug;37(12):3226-3244. doi: 10.1080/07391102.2018.1513379. Epub 2018 Dec 24.
7
Repurposing drugs for use against Zika virus infection.重新利用药物治疗寨卡病毒感染。
SAR QSAR Environ Res. 2018 Feb;29(2):103-115. doi: 10.1080/1062936X.2017.1411642. Epub 2018 Jan 4.
8
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.基于结构的已上市药物发现作为 Zika 病毒 NS2B-NS3 蛋白酶抑制剂,在体外和体内强效抑制 Zika 病毒感染。
Antiviral Res. 2017 Sep;145:33-43. doi: 10.1016/j.antiviral.2017.07.007. Epub 2017 Jul 14.
9
In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation.基于定量构效关系、分子对接和药代动力学参数计算预测苯并咪唑类促肾上腺皮质激素释放因子-1 受体拮抗剂的体内结合机制。
J Biomol Struct Dyn. 2018 May;36(7):1691-1712. doi: 10.1080/07391102.2017.1332688. Epub 2017 Jun 12.
10
Zika virus cell tropism in the developing human brain and inhibition by azithromycin.寨卡病毒在发育中的人类大脑中的细胞嗜性及阿奇霉素对其的抑制作用
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413. doi: 10.1073/pnas.1618029113. Epub 2016 Nov 29.